Try GOLD - Free
Patients Have More Choices To Tackle High Cholesterol
The Wall Street Journal
|November 10, 2025
Researchers present latest study results of alternatives beyond statins that are on the horizon
CLOCKWISE FROM TOP: CRISPR MERCK; AMGEN
Astatin isn't the only answer anymore to lowering cholesterol.
This story is from the November 10, 2025 edition of The Wall Street Journal.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
Listen
Translate
-
+
Change font size